Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tomuzotuximab |
| Trade Name | |
| Synonyms | CetuGEX |
| Drug Descriptions |
Tomuzotuximab is a second-generation EGFR antibody, which potentially induces antibody-dependent cellular cytotoxicity (ADCC) against tumor cells (PMID: 29464112; PMID: 35397434). |
| DrugClasses | EGFR Antibody 72 |
| CAS Registry Number | 1646321-00-7 |
| NCIT ID | C152692 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cisplatin + Fluorouracil + Tomuzotuximab | Cisplatin Fluorouracil Tomuzotuximab | 0 | 0 |
| Gatipotuzumab + Tomuzotuximab | Gatipotuzumab Tomuzotuximab | 0 | 0 |
| Tomuzotuximab | Tomuzotuximab | 0 | 0 |